[ON DEMAND] Designing an mRNA process development platform: a quality by design approach

Expediting Biologics preclinical development timeline through downstream strategies | Webinar

Samsung Biologics の CDO 機能

バイオデジタル2021 | CDMO の観点から見たサムスン バイオロジクスとの対話

Interview with The Korea Society: Vaccine Cooperation

Business Review | Partnering with CDMOs for a sustainable future

Samsung Biologics signs vaccine production deal with Moderna

Manufacturing concepts for antibody-drug conjugates | Webinar

BMWS 2020 | Quality Digital Transformation

イノベーションへの適応: バイオ製造における課題を機会に変える |ネクストファーマ（ネクストノーマル）

CDMO 市場をナビゲートする: ハードル、変革、機会

On-Demand Webinar | Enhancing quality by employing cell line replacement and process optimization

Innov-daptation: Shifting Challenges to Opportunity in Bio Manufacturing

[EN] BlueBetterFly "Shaping the Future of Pharma" Event (US)

[KR] BlueBetterFly "Shaping the Future of Pharma" Event (US)

The Next Wave with Young Sohn – Will AI Become the New Standard in Medical Care?

How Single-Use Technology Is Meeting the Demand for Commercial Biologics Manufacturing

"Monoclonal Antibody Manufacturing: Transforming Our Most Important Biologics Manufacturing Process"

Why Samsung Is Doing This

What are Biologics?